nodes	percent_of_prediction	percent_of_DWPC	metapath
Xylometazoline—HTR1D—autistic disorder	0.506	0.627	CbGaD
Xylometazoline—HTR1B—autistic disorder	0.3	0.372	CbGaD
Xylometazoline—HTR1B—telencephalic ventricle—autistic disorder	0.0059	0.104	CbGeAlD
Xylometazoline—HTR1D—telencephalic ventricle—autistic disorder	0.00571	0.101	CbGeAlD
Xylometazoline—Oxymetazoline—HTR1D—autistic disorder	0.00336	0.526	CrCbGaD
Xylometazoline—ADRA1A—hindbrain—autistic disorder	0.00207	0.0367	CbGeAlD
Xylometazoline—ADRA1D—forebrain—autistic disorder	0.00199	0.0353	CbGeAlD
Xylometazoline—Oxymetazoline—HTR1B—autistic disorder	0.00199	0.312	CrCbGaD
Xylometazoline—ADRA1D—telencephalon—autistic disorder	0.00183	0.0325	CbGeAlD
Xylometazoline—HTR1B—brainstem—autistic disorder	0.0016	0.0282	CbGeAlD
Xylometazoline—HTR1D—brainstem—autistic disorder	0.00154	0.0273	CbGeAlD
Xylometazoline—HTR1B—forebrain—autistic disorder	0.00154	0.0273	CbGeAlD
Xylometazoline—HTR1D—eye—autistic disorder	0.0015	0.0266	CbGeAlD
Xylometazoline—HTR1D—forebrain—autistic disorder	0.00149	0.0264	CbGeAlD
Xylometazoline—HTR1B—telencephalon—autistic disorder	0.00142	0.0251	CbGeAlD
Xylometazoline—HTR1D—telencephalon—autistic disorder	0.00137	0.0243	CbGeAlD
Xylometazoline—ADRA1A—brainstem—autistic disorder	0.00119	0.021	CbGeAlD
Xylometazoline—ADRA1B—head—autistic disorder	0.00117	0.0207	CbGeAlD
Xylometazoline—ADRA1A—forebrain—autistic disorder	0.00115	0.0203	CbGeAlD
Xylometazoline—ADRA1D—head—autistic disorder	0.00114	0.0202	CbGeAlD
Xylometazoline—ADRA1B—nervous system—autistic disorder	0.00111	0.0196	CbGeAlD
Xylometazoline—ADRA1D—nervous system—autistic disorder	0.00108	0.0192	CbGeAlD
Xylometazoline—ADRA1B—central nervous system—autistic disorder	0.00107	0.0189	CbGeAlD
Xylometazoline—ADRA1A—telencephalon—autistic disorder	0.00105	0.0186	CbGeAlD
Xylometazoline—ADRA1D—central nervous system—autistic disorder	0.00104	0.0185	CbGeAlD
Xylometazoline—Oxymetazoline—HTR2A—autistic disorder	0.00103	0.162	CrCbGaD
Xylometazoline—ADRA2C—telencephalon—autistic disorder	0.001	0.0178	CbGeAlD
Xylometazoline—HTR1B—head—autistic disorder	0.000882	0.0156	CbGeAlD
Xylometazoline—ADRA2A—forebrain—autistic disorder	0.000871	0.0154	CbGeAlD
Xylometazoline—HTR1D—head—autistic disorder	0.000854	0.0151	CbGeAlD
Xylometazoline—ADRA1B—brain—autistic disorder	0.000846	0.015	CbGeAlD
Xylometazoline—HTR1B—nervous system—autistic disorder	0.000836	0.0148	CbGeAlD
Xylometazoline—ADRA1D—brain—autistic disorder	0.000828	0.0146	CbGeAlD
Xylometazoline—HTR1D—nervous system—autistic disorder	0.000809	0.0143	CbGeAlD
Xylometazoline—HTR1B—central nervous system—autistic disorder	0.000805	0.0142	CbGeAlD
Xylometazoline—ADRA2A—telencephalon—autistic disorder	0.000801	0.0142	CbGeAlD
Xylometazoline—HTR1D—central nervous system—autistic disorder	0.000779	0.0138	CbGeAlD
Xylometazoline—ADRA1A—head—autistic disorder	0.000656	0.0116	CbGeAlD
Xylometazoline—HTR1B—brain—autistic disorder	0.000639	0.0113	CbGeAlD
Xylometazoline—ADRA2C—head—autistic disorder	0.000625	0.0111	CbGeAlD
Xylometazoline—ADRA1A—nervous system—autistic disorder	0.000622	0.011	CbGeAlD
Xylometazoline—HTR1D—brain—autistic disorder	0.000619	0.0109	CbGeAlD
Xylometazoline—ADRA1A—central nervous system—autistic disorder	0.000599	0.0106	CbGeAlD
Xylometazoline—ADRA2C—nervous system—autistic disorder	0.000593	0.0105	CbGeAlD
Xylometazoline—ADRA1A—cerebellum—autistic disorder	0.000585	0.0104	CbGeAlD
Xylometazoline—ADRA2C—central nervous system—autistic disorder	0.000571	0.0101	CbGeAlD
Xylometazoline—ADRA2C—cerebellum—autistic disorder	0.000558	0.00987	CbGeAlD
Xylometazoline—ADRA2A—head—autistic disorder	0.000499	0.00883	CbGeAlD
Xylometazoline—ADRA1A—brain—autistic disorder	0.000475	0.00841	CbGeAlD
Xylometazoline—ADRA2A—nervous system—autistic disorder	0.000473	0.00837	CbGeAlD
Xylometazoline—ADRA2A—central nervous system—autistic disorder	0.000455	0.00806	CbGeAlD
Xylometazoline—ADRA2C—brain—autistic disorder	0.000453	0.00802	CbGeAlD
Xylometazoline—ADRA2A—cerebellum—autistic disorder	0.000445	0.00788	CbGeAlD
Xylometazoline—ADRA2A—brain—autistic disorder	0.000361	0.0064	CbGeAlD
Xylometazoline—ADRA2B—Signaling Pathways—ADRB2—autistic disorder	1.19e-05	9.05e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—PIK3CG—autistic disorder	1.18e-05	9.03e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—HTR2A—autistic disorder	1.18e-05	8.96e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—IL2—autistic disorder	1.18e-05	8.96e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—POMC—autistic disorder	1.17e-05	8.93e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—PLA2G4A—autistic disorder	1.17e-05	8.93e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—GSTM1—autistic disorder	1.17e-05	8.93e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—IL5—autistic disorder	1.17e-05	8.92e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—PRL—autistic disorder	1.17e-05	8.91e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—PLA2G4A—autistic disorder	1.16e-05	8.85e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CALCA—autistic disorder	1.16e-05	8.81e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Hemostasis—MAPK1—autistic disorder	1.15e-05	8.8e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—POMC—autistic disorder	1.15e-05	8.79e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—PRKCB—autistic disorder	1.15e-05	8.77e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—PRL—autistic disorder	1.15e-05	8.77e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—TSC1—autistic disorder	1.15e-05	8.75e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—DRD1—autistic disorder	1.15e-05	8.75e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—TSC2—autistic disorder	1.14e-05	8.69e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—IL2—autistic disorder	1.13e-05	8.62e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—MEF2C—autistic disorder	1.13e-05	8.61e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—POMC—autistic disorder	1.13e-05	8.6e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—PRKCB—autistic disorder	1.12e-05	8.57e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—GPX1—autistic disorder	1.12e-05	8.55e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—CYP19A1—autistic disorder	1.12e-05	8.53e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—TSC2—autistic disorder	1.12e-05	8.51e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—APOE—autistic disorder	1.12e-05	8.51e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—LEP—autistic disorder	1.12e-05	8.51e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—NTRK2—autistic disorder	1.12e-05	8.51e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—AVP—autistic disorder	1.12e-05	8.5e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—DRD3—autistic disorder	1.11e-05	8.47e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—IGF2—autistic disorder	1.11e-05	8.46e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—ADRB2—autistic disorder	1.11e-05	8.45e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—PIK3CG—autistic disorder	1.1e-05	8.39e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—ITGB3—autistic disorder	1.1e-05	8.39e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—LEP—autistic disorder	1.09e-05	8.33e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—APOE—autistic disorder	1.09e-05	8.33e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—ADRB2—autistic disorder	1.09e-05	8.32e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—IL5—autistic disorder	1.09e-05	8.29e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—PIK3CG—autistic disorder	1.08e-05	8.2e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CALCA—autistic disorder	1.07e-05	8.19e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—PRKCB—autistic disorder	1.05e-05	8.02e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—PLA2G4A—autistic disorder	1.05e-05	7.99e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—POMC—autistic disorder	1.05e-05	7.99e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—PRKCB—autistic disorder	1.04e-05	7.96e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—AVP—autistic disorder	1.04e-05	7.94e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—COMT—autistic disorder	1.04e-05	7.93e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—IGF2—autistic disorder	1.04e-05	7.9e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—GSTP1—autistic disorder	1.04e-05	7.89e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—MTHFR—autistic disorder	1.04e-05	7.89e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—MAOA—autistic disorder	1.03e-05	7.87e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—PRKCB—autistic disorder	1.03e-05	7.86e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—HTR2A—autistic disorder	1.03e-05	7.83e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—IL2—autistic disorder	1.03e-05	7.83e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—AVP—autistic disorder	1.03e-05	7.81e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—POMC—autistic disorder	1.02e-05	7.81e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—PRL—autistic disorder	1.02e-05	7.79e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—IL2—autistic disorder	1.02e-05	7.78e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—IGF2—autistic disorder	1.02e-05	7.78e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—MEF2C—autistic disorder	1.02e-05	7.77e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—PIK3CG—autistic disorder	1.01e-05	7.68e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—APC—autistic disorder	1.01e-05	7.68e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—CAT—autistic disorder	1.01e-05	7.68e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—PIK3CG—autistic disorder	1e-05	7.62e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—EGF—autistic disorder	9.96e-06	7.59e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—ITGB3—autistic disorder	9.94e-06	7.57e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Hemostasis—HRAS—autistic disorder	9.92e-06	7.56e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—APC—autistic disorder	9.86e-06	7.52e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—PIK3CG—autistic disorder	9.86e-06	7.52e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—PLA2G4A—autistic disorder	9.79e-06	7.46e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—TSC2—autistic disorder	9.76e-06	7.44e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—EGF—autistic disorder	9.75e-06	7.43e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—ADRB2—autistic disorder	9.69e-06	7.39e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—PLA2G4A—autistic disorder	9.64e-06	7.35e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—APOE—autistic disorder	9.64e-06	7.34e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—POMC—autistic disorder	9.59e-06	7.31e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—LEP—autistic disorder	9.55e-06	7.28e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—APOE—autistic disorder	9.55e-06	7.28e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—IL2—autistic disorder	9.54e-06	7.27e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—MEF2C—autistic disorder	9.53e-06	7.26e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—POMC—autistic disorder	9.52e-06	7.25e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—PLA2G4A—autistic disorder	9.51e-06	7.25e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—GSTM1—autistic disorder	9.51e-06	7.25e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—PRL—autistic disorder	9.49e-06	7.23e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—POMC—autistic disorder	9.39e-06	7.16e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—IL2—autistic disorder	9.39e-06	7.15e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Hemostasis—MAPK1—autistic disorder	9.38e-06	7.15e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—MEF2C—autistic disorder	9.38e-06	7.15e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—ITGB3—autistic disorder	9.28e-06	7.08e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—HTR2A—autistic disorder	9.28e-06	7.07e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—IL2—autistic disorder	9.27e-06	7.07e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Hemostasis—HRAS—autistic disorder	9.27e-06	7.06e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—IGF1—autistic disorder	9.22e-06	7.03e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—MAPK1—autistic disorder	9.18e-06	7e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—ITGB3—autistic disorder	9.14e-06	6.96e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—GPX1—autistic disorder	9.11e-06	6.94e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—AVP—autistic disorder	9.11e-06	6.94e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—IGF2—autistic disorder	9.07e-06	6.91e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—IGF1—autistic disorder	9.03e-06	6.88e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—PRKCB—autistic disorder	9.01e-06	6.87e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—ADRB2—autistic disorder	9.01e-06	6.86e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—MAPK1—autistic disorder	8.99e-06	6.85e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—TSC2—autistic disorder	8.81e-06	6.72e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—SERPINE1—autistic disorder	8.76e-06	6.68e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—PIK3CG—autistic disorder	8.7e-06	6.63e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—HTR2A—autistic disorder	8.67e-06	6.61e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—IL2—autistic disorder	8.66e-06	6.6e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—LEP—autistic disorder	8.63e-06	6.57e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—APOE—autistic disorder	8.63e-06	6.57e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—PIK3CG—autistic disorder	8.62e-06	6.57e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—APC—autistic disorder	8.62e-06	6.57e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—SERPINE1—autistic disorder	8.58e-06	6.54e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—PLA2G4A—autistic disorder	8.56e-06	6.52e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—HTR2A—autistic disorder	8.53e-06	6.5e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—IL2—autistic disorder	8.53e-06	6.5e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—EGF—autistic disorder	8.52e-06	6.5e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—AVP—autistic disorder	8.46e-06	6.45e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—IGF2—autistic disorder	8.42e-06	6.42e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—MTHFR—autistic disorder	8.41e-06	6.41e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—IL2—autistic disorder	8.34e-06	6.36e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—MEF2C—autistic disorder	8.33e-06	6.35e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—POMC—autistic disorder	8.28e-06	6.31e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—TSC2—autistic disorder	8.23e-06	6.27e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—POMC—autistic disorder	8.21e-06	6.26e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—PRKCB—autistic disorder	8.13e-06	6.2e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—ITGB3—autistic disorder	8.12e-06	6.19e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—TSC2—autistic disorder	8.1e-06	6.18e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—LEP—autistic disorder	8.06e-06	6.14e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—APOE—autistic disorder	8.06e-06	6.14e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—PLA2G4A—autistic disorder	7.95e-06	6.06e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—LEP—autistic disorder	7.93e-06	6.04e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—APOE—autistic disorder	7.93e-06	6.04e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—IGF1—autistic disorder	7.89e-06	6.02e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—MAPK1—autistic disorder	7.86e-06	5.99e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—APOE—autistic disorder	7.83e-06	5.96e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—APC—autistic disorder	7.78e-06	5.93e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—PIK3CG—autistic disorder	7.78e-06	5.93e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—IL2—autistic disorder	7.75e-06	5.9e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—MEF2C—autistic disorder	7.74e-06	5.9e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—EGF—autistic disorder	7.69e-06	5.86e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—PRKCB—autistic disorder	7.6e-06	5.79e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—HTR2A—autistic disorder	7.58e-06	5.77e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—IL2—autistic disorder	7.57e-06	5.77e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—ITGB3—autistic disorder	7.54e-06	5.75e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Hemostasis—HRAS—autistic disorder	7.53e-06	5.74e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—SERPINE1—autistic disorder	7.5e-06	5.71e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—PRKCB—autistic disorder	7.48e-06	5.7e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—POMC—autistic disorder	7.41e-06	5.65e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—HRAS—autistic disorder	7.37e-06	5.62e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—APC—autistic disorder	7.27e-06	5.54e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—PIK3CG—autistic disorder	7.27e-06	5.54e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—HRAS—autistic disorder	7.22e-06	5.5e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—TSC2—autistic disorder	7.2e-06	5.49e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—EGF—autistic disorder	7.19e-06	5.48e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—APC—autistic disorder	7.16e-06	5.45e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—PIK3CG—autistic disorder	7.16e-06	5.45e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—IGF1—autistic disorder	7.13e-06	5.43e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—MAPK1—autistic disorder	7.09e-06	5.41e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—IL2—autistic disorder	7.09e-06	5.4e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—EGF—autistic disorder	7.07e-06	5.39e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—PIK3CG—autistic disorder	7.06e-06	5.38e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—IL6—autistic disorder	7.05e-06	5.38e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—APOE—autistic disorder	7.04e-06	5.37e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—LEP—autistic disorder	7.04e-06	5.37e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—HTR2A—autistic disorder	7.04e-06	5.37e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—IL2—autistic disorder	7.04e-06	5.36e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—IL2—autistic disorder	6.94e-06	5.29e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—POMC—autistic disorder	6.92e-06	5.28e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—IL6—autistic disorder	6.91e-06	5.26e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—POMC—autistic disorder	6.81e-06	5.19e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—SERPINE1—autistic disorder	6.77e-06	5.16e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—POMC—autistic disorder	6.72e-06	5.12e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—TSC2—autistic disorder	6.69e-06	5.1e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—PTEN—autistic disorder	6.67e-06	5.08e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—IGF1—autistic disorder	6.66e-06	5.07e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—PRKCB—autistic disorder	6.64e-06	5.06e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—MAPK1—autistic disorder	6.63e-06	5.05e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—PTGS2—autistic disorder	6.6e-06	5.03e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—IGF1—autistic disorder	6.55e-06	4.99e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—APOE—autistic disorder	6.54e-06	4.99e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—LEP—autistic disorder	6.54e-06	4.99e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—PTEN—autistic disorder	6.53e-06	4.98e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—MAPK1—autistic disorder	6.52e-06	4.97e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—PIK3CG—autistic disorder	6.36e-06	4.84e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—APC—autistic disorder	6.36e-06	4.84e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—SERPINE1—autistic disorder	6.32e-06	4.82e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—HRAS—autistic disorder	6.31e-06	4.81e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—EGF—autistic disorder	6.28e-06	4.79e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—SERPINE1—autistic disorder	6.22e-06	4.74e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—PRKCB—autistic disorder	6.17e-06	4.7e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—IL2—autistic disorder	6.07e-06	4.62e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—POMC—autistic disorder	6.05e-06	4.61e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—IL6—autistic disorder	6.04e-06	4.6e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—APC—autistic disorder	5.91e-06	4.5e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—PIK3CG—autistic disorder	5.91e-06	4.5e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—EGF—autistic disorder	5.84e-06	4.45e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—IGF1—autistic disorder	5.82e-06	4.44e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—MAPK1—autistic disorder	5.79e-06	4.41e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—PTEN—autistic disorder	5.76e-06	4.39e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—PTEN—autistic disorder	5.71e-06	4.35e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—HRAS—autistic disorder	5.7e-06	4.34e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—POMC—autistic disorder	5.62e-06	4.28e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—SERPINE1—autistic disorder	5.53e-06	4.21e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—IL2—autistic disorder	5.48e-06	4.17e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—IL6—autistic disorder	5.45e-06	4.15e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—MAPK1—autistic disorder	5.42e-06	4.13e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—IGF1—autistic disorder	5.41e-06	4.12e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—MAPK1—autistic disorder	5.38e-06	4.1e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—PTGS2—autistic disorder	5.36e-06	4.09e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—HRAS—autistic disorder	5.32e-06	4.05e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—MAPK1—autistic disorder	5.31e-06	4.05e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—HRAS—autistic disorder	5.24e-06	3.99e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—PTEN—autistic disorder	5.15e-06	3.93e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—SERPINE1—autistic disorder	5.14e-06	3.91e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—IL2—autistic disorder	5.12e-06	3.9e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—IL6—autistic disorder	5.09e-06	3.88e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—IL2—autistic disorder	5.04e-06	3.84e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—IL6—autistic disorder	5.01e-06	3.82e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—PTEN—autistic disorder	4.81e-06	3.67e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—PTEN—autistic disorder	4.74e-06	3.61e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—PTEN—autistic disorder	4.68e-06	3.56e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—HRAS—autistic disorder	4.65e-06	3.54e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—MAPK1—autistic disorder	4.64e-06	3.54e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—IL2—autistic disorder	4.47e-06	3.41e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—IL6—autistic disorder	4.45e-06	3.39e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—HRAS—autistic disorder	4.35e-06	3.32e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—HRAS—autistic disorder	4.32e-06	3.29e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—HRAS—autistic disorder	4.26e-06	3.25e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—PTEN—autistic disorder	4.21e-06	3.21e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—MAPK1—autistic disorder	4.19e-06	3.19e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—IL6—autistic disorder	4.17e-06	3.18e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—IL2—autistic disorder	4.16e-06	3.17e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—IL6—autistic disorder	4.14e-06	3.15e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—IL6—autistic disorder	4.08e-06	3.11e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—MAPK1—autistic disorder	3.91e-06	2.98e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—PTEN—autistic disorder	3.91e-06	2.98e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—MAPK1—autistic disorder	3.85e-06	2.94e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—HRAS—autistic disorder	3.73e-06	2.84e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—IL6—autistic disorder	3.57e-06	2.72e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—MAPK1—autistic disorder	3.42e-06	2.61e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—HRAS—autistic disorder	3.36e-06	2.56e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—IL6—autistic disorder	3.22e-06	2.45e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—MAPK1—autistic disorder	3.18e-06	2.42e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—HRAS—autistic disorder	3.14e-06	2.39e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—HRAS—autistic disorder	3.09e-06	2.36e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—IL6—autistic disorder	3.01e-06	2.29e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—IL6—autistic disorder	2.96e-06	2.26e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—HRAS—autistic disorder	2.75e-06	2.09e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—IL6—autistic disorder	2.63e-06	2e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—HRAS—autistic disorder	2.55e-06	1.95e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—IL6—autistic disorder	2.44e-06	1.86e-05	CbGpPWpGaD
